Skip to main content
Premium Trial:

Request an Annual Quote

John Burcham, Terrie Pizzie, Mathias Uhln, and Eric Lander

Premium

John Burcham has joined Applied Biosystems as senior marketing manager for TaqMan SNP genotyping assays, GenomeWeb News has learned. He came to ABI from GE Healthcare, formerly Amersham, where he was strategic marketing manager for proteomics. Prior to that, he held technical specialist and marketing positions at Bio-Rad. Burcham holds a BA from the University of California, Berkeley.


Terrie Pizzie will become senior vice president of commercial operations at Biacore International starting March 1, the company said last week. Prior to joining the company, he was vice president Europe of Applied Biosystems. Before that, he was ABI’s director of sales and marketing in Europe.


Mathias Uhlén will receive this year’s Akzo Nobel science award on March 15, the Netherlands-based company said last week. He is a professor at the Royal Institute of Technology in Stockholm, Sweden. Uhlén receives the 500,000 Swedish kronor ($72,600) award “for his unique research in the field of biotechnology and his ability to bridge research and industry,” according to Akzo. He founded a number of biotechnology companies, including Pyrosequencing, Affibody, Creative Peptides, SweTree Genomics, and Visual Bioinformatics. Uhlén also initiated a project at his institute to map 22,000 human proteins. The Akzo Nobel science award alternates between Sweden and the Netherlands every year.


Eric Lander will receive this year’s Public Understanding of Science and Technology award from the American Association for the Advancement of Science, AAAS said last week. He is the founding director of the Broad Institute of MIT and Harvard and a professor of biology at MIT, a professor of systems biology at Harvard Medical School, and a member of the Whitehead Institute for Biomedical Research. Lander holds a PhD in mathematics from Oxford University and an undergraduate degree in mathematics from Princeton University.

 

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.